Latest Health News
Garaherb Claims Evaluated: Complete Scientific Investigation of Ingredients’ Effectiveness
Aurora, CO, March 20, 2026 (GLOBE NEWSWIRE) -- Editor's Note: The terms…
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
March 20, 2026 13:30 ET | Source: SANUWAVE Health, Inc. EDEN PRAIRIE,…
Disclosure of a transparency notification from Aberdeen Group plc
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM…
SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting
KNOXVILLE, TN., March 20, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:…
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcytes 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
March 18, 2026 19:34 ET | Source: Vaxcyte, Inc. Based on the…
2026 MAP Awards presented to 20 organizations for high performance in revenue cycle
CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association…
VitalHub Reports Fourth Quarter 2025 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up…
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc. MIAMI, March…
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: CytomX Therapeutics Inc. SOUTH SAN…
